LINTEC Corporation - 7966.T

7966.T Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
7966.T	-0.3	-1.6	-2.4	-9.5	-14.8	12.1	8.6	20.8	15.8	188.5
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare 7966.T with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	7966.T
name	LINTEC Corporation
price	2951
changes percentage	-0.3377
change	-10
day low	2932
day high	2965
year high	3665
year low	2454
market cap	202142393375
price avg 50	3052.02
price avg 200	3187.48
exchange	JPX
volume	128200
avg volume	201406
open	2960
previous close	2961
eps	205.82
pe	14.34
earnings announcement	2025-02-06T04:00:00.000+0000
shares outstanding	68499625
timestamp	2025-01-17 06:45:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.0%

Overall Quarterly Financial Health: 60.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	276321000000	284603000000	-2.91
gross profit	61408000000	63175000000	-2.80
gross profit ratio	0.22	0.22	0.12
research and development expenses	9036000000	9069000000	-0.36
operating expenses	50780000000	49375000000	2.85
interest income	471000000	292000000	61.30
interest expense	398000000	116000000	243.10
ebitda	25753000000	28687000000	-10.23
ebitdaratio	0.09	0.11	-13.98
operating income	10629000000	13796000000	-22.96
operating income ratio	0.04	0.05	-20.65
net income	5243000000	11512000000	-54.46
net income ratio	0.02	0.04	-53.09
eps	76.66	167.84	-54.33

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 276,321 million in 2024 from 284,603 million in 2023 representing a change of -2.91%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 61,408 million in 2024 from 63,175 million in 2023 representing a change of -2.8%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 9,036 million in 2024 from 9,069 million in 2023 representing a change of -0.36%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 50,780 million in 2024 from 49,375 million in 2023 representing a change of 2.85%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 25,753 million in 2024 from 28,687 million in 2023 representing a change of -10.23%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 10,629 million in 2024 from 13,796 million in 2023 representing a change of -22.96%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 76.66 in 2024 from 76.66 in 2023 representing a change of -54.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Net Income: Net income increased to 5,243 million in 2024 from 11,512 million in 2023 representing a change of -54.46%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	76045000000	72792000000	4.47
gross profit	20075000000	17374000000	15.55
gross profit ratio	0.26	0.24	10.60
research and development expenses	0	2350000000	-100.00
operating expenses	13640000000	13262000000	2.85
interest income	150000000	159000000	-5.66
interest expense	105000000	111000000	-5.41
ebitda	10661000000	8436000000	26.38
ebitdaratio	0.14	0.12	20.97
operating income	6435000000	4112000000	56.49
operating income ratio	0.08	0.06	49.80
net income	5890000000	1249000000	371.58
net income ratio	0.08	0.02	351.40
eps	86.1	18.26	371.52

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 76,045 million in 2025Q1 from 72,792 million in 2024Q4 representing a change of 4.47%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 20,075 million in 2025Q1 from 17,374 million in 2024Q4 representing a change of 15.55%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Income: Operating income increased to 6,435 million in 2025Q1 from 4,112 million in 2024Q4 representing a change of 56.49%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 5,890 million in 2025Q1 from 1,249 million in 2024Q4 representing a change of 371.58%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 86.1 in 2025Q1 from 86.1 in 2024Q4 representing a change of 371.52%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 2,350 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 13,640 million in 2025Q1 from 13,262 million in 2024Q4 representing a change of 2.85%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 10,661 million in 2025Q1 from 8,436 million in 2024Q4 representing a change of 26.38%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	333642000000	304881000000	9.43
total liabilities	100660000000	77734000000	29.49
total equity	232984000000	227147000000	2.57
cash and cash equivalents	55490000000	38032000000	45.90
short term investments	3094000000	-6147000000	150.33
long term investments	2473000000	8489000000	-70.87
total current assets	187977000000	171936000000	9.33
total non current assets	145665000000	132940000000	9.57
total current liabilities	75918000000	59823000000	26.90
total non current liabilities	24742000000	17911000000	38.14
common stock	23355000000	23355000000	0.00
retained earnings	170796000000	171325000000	-0.31
total debt	9262000000	2562000000	261.51

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 333,642 million in 2024 from 304,881 million in 2023 representing a change of 9.43%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 232,984 million in 2024 from 227,147 million in 2023 representing a change of 2.57%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 55,490 million in 2024 from 38,032 million in 2023 representing a change of 45.9%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 3,094 million in 2024 from -6,147 million in 2023 representing a change of 150.33%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 187,977 million in 2024 from 171,936 million in 2023 representing a change of 9.33%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 100,660 million in 2024 from 77,734 million in 2023 representing a change of 29.49%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 75,918 million in 2024 from 59,823 million in 2023 representing a change of 26.9%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 170,796 million in 2024 from 171,325 million in 2023 representing a change of -0.31%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 9,262 million in 2024 from 2,562 million in 2023 representing a change of 261.51%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	341323000000	333642000000	2.30
total liabilities	100170000000	100656000000	-0.48
total equity	241153000000	232984000000	3.51
cash and cash equivalents	55508000000	52396000000	5.94
short term investments	0	3094000000	-100.00
long term investments	12663000000	2473000000	412.05
total current assets	193707000000	187977000000	3.05
total non current assets	147616000000	145665000000	1.34
total current liabilities	75734000000	75918000000	-0.24
total non current liabilities	24436000000	24738000000	-1.22
common stock	23355000000	23355000000	0.00
retained earnings	173676000000	170796000000	1.69
total debt	7623000000	14511000000	-47.47

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 341,323 million in 2025Q1 from 333,642 million in 2024Q4 representing a change of 2.3%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 100,170 million in 2025Q1 from 100,656 million in 2024Q4 representing a change of -0.48%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 241,153 million in 2025Q1 from 232,984 million in 2024Q4 representing a change of 3.51%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 55,508 million in 2025Q1 from 52,396 million in 2024Q4 representing a change of 5.94%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 193,707 million in 2025Q1 from 187,977 million in 2024Q4 representing a change of 3.05%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 75,734 million in 2025Q1 from 75,918 million in 2024Q4 representing a change of -0.24%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 173,676 million in 2025Q1 from 170,796 million in 2024Q4 representing a change of 1.69%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 7,623 million in 2025Q1 from 14,511 million in 2024Q4 representing a change of -47.47%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 0 million in 2025Q1 from 3,094 million in 2024Q4 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	18539000000	-16746000000	210.71
operating cash flow	39205000000	5936000000	560.46
free cash flow	24277000000	-7792000000	411.56
capital expenditure	-14928000000	-13728000000	-8.74
depreciation and amortization	15902000000	14890000000	6.80
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	6242000000	-9976000000	162.57
inventory	10915000000	-11751000000	192.89
acquisitions net	-7967000000	316000000	-2621.20
investments in property plant and equipment	-14928000000	-13728000000	-8.74
net cash used for investing activites	-21512000000	-12138000000	-77.23
debt repayment	5559000000	-1930000000	388.03
common stock issued	0	0	NaN
common stock repurchased	-1000000	-3555000000	99.97
dividends paid	-6017000000	-6426000000	6.36
net cash used provided by financing activities	-1288000000	-12775000000	89.92
cash at end of period	52396000000	33857000000	54.76
accounts receivables	-3130000000	5606000000	-155.83
cash at beginning of period	33857000000	50603000000	-33.09

Overall Score of Annual Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 18,539 million in 2024 from -16,746 million in 2023 representing a change of 210.71%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 39,205 million in 2024 from 5,936 million in 2023 representing a change of 560.46%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 24,277 million in 2024 from -7,792 million in 2023 representing a change of 411.56%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -14,928 million in 2024 from -13,728 million in 2023 representing a change of -8.74%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 6,242 million in 2024 from 9,976 million in 2023 representing a change of 162.57%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -3,130 million in 2024 from 5,606 million in 2023 representing a change of -155.83%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -6,017 million in 2024 from -6,426 million in 2023 representing a change of 6.36%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	8573000000	14213000000	-39.68
free cash flow	3605000000	10582000000	-65.93
capital expenditure	-4968000000	-3631000000	-36.82
depreciation and amortization	4224000000	4324000000	-2.31
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-1413000000	2007000000	-170.40
accounts payables	2040000000	1755000000	16.24
inventory	-2343000000	1709000000	-237.10
acquisitions net	135000000	-1067000000	112.65
investments in property plant and equipment	-4999000000	-3631000000	-37.68
net cash used for investing activites	-5203000000	-4974000000	-4.60
debt repayment	-821000000	993000000	-182.68
common stock issued	0	0	NaN
common stock repurchased	0	-1000000	100.00
dividends paid	-2989000000	-8000000	-37262.50
net cash used provided by financing activities	-5160000000	772000000	-768.39
net change in cash	3112000000	9407000000	-66.92
cash at end of period	55508000000	52396000000	5.94
cash at beginning of period	52396000000	42989000000	21.88

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 3,112 million in 2025Q1 from 9,407 million in 2024Q4 representing a change of -66.92%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 8,573 million in 2025Q1 from 14,213 million in 2024Q4 representing a change of -39.68%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 3,605 million in 2025Q1 from 10,582 million in 2024Q4 representing a change of -65.93%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 2,040 million in 2025Q1 from 1,755 million in 2024Q4 representing a change of 16.24%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -2,989 million in 2025Q1 from -8 million in 2024Q4 representing a change of -37262.5%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -4,968 million in 2025Q1 from -3,631 million in 2024Q4 representing a change of -36.82%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -1,413 million in 2025Q1 from 2,007 million in 2024Q4 representing a change of -170.4%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	4040.08	4149.28	-2.63
net income per share	76.66	167.84	-54.33
operating cash flow per share	573.21	86.54	562.35
free cash flow per share	354.95	-113.6	412.46
cash per share	856.55	464.86	84.26
book value per share	3406.42	3311.62	2.86
tangible book value per share	3138.87	3053.46	2.80
shareholders equity per share	3396.17	3301.19	2.88
interest debt per share	141.24	39.04	261.75
market cap	209972650000	148499515000	41.40
enterprise value	163744650000	113029515000	44.87
pe ratio	40.05	12.9	210.46
price to sales ratio	0.76	0.52	45.63
pocfratio	5.36	25.02	-78.59
pfcf ratio	8.65	-19.06	145.38
pb ratio	0.9	0.66	37.84
ptb ratio	0.9	0.66	37.84
ev to sales	0.59	0.4	49.21
enterprise value over ebitda	6.36	3.94	61.37
ev to operating cash flow	4.18	19.04	-78.07
ev to free cash flow	6.74	-14.51	146.50
earnings yield	0.02	0.08	-67.79
free cash flow yield	0.12	-0.05	320.35
debt to equity	0.04	0.01	252.41
debt to assets	0.03	0.01	230.35
net debt to ebitda	-1.8	-1.24	-45.18
current ratio	2.48	2.87	-13.85
interest coverage	26.71	118.93	-77.54
income quality	7.48	0.37	1897.76
dividend yield	0.03	0.04	-33.78
payout ratio	1.15	0.56	105.59
sales general and administrative to revenue	0.12	0.02	507.82
research and ddevelopement to revenue	0.03	0.03	2.62
intangibles to total assets	0.05	0.06	-5.57
capex to operating cash flow	0.38	2.31	-83.54
capex to revenue	0.05	0.05	12.00
capex to depreciation	0.94	0.92	1.82
stock based compensation to revenue	0	0	NaN
graham number	2420.27	3530.76	-31.45
roic	0.02	0.04	-44.78
return on tangible assets	0.02	0.04	-58.52
graham net net	528.32	463.06	14.09
working capital	112059000000	112113000000	-0.05
tangible asset value	214683000000	209440000000	2.50
net current asset value	87317000000	94202000000	-7.31
invested capital	244483000000	231410000000	5.65
average receivables	61615000000	60468500000	1.90
average payables	41342500000	38526000000	7.31
average inventory	63399000000	59893000000	5.85
days sales outstanding	85.31	75.22	13.42
days payables outstanding	77.62	60.96	27.34
days of inventory on hand	101.13	110.85	-8.77
receivables turnover	4.28	4.85	-11.83
payables turnover	4.7	5.99	-21.47
inventory turnover	3.61	3.29	9.61
roe	0.02	0.05	-55.60
capex per share	218.26	200.14	9.05

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-03-31 from 0.05 on 2023-03-31, representing a change of -55.60%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 40.05 on 2024-03-31 from 12.90 on 2023-03-31, representing a change of 210.46%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.48 on 2024-03-31 from 2.87 on 2023-03-31, representing a change of -13.85%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.04 on 2024-03-31 from 0.01 on 2023-03-31, representing a change of 252.41%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
7966.T
calendar year	2025	2024	NaN
revenue per share	1111.57	1064.16	4.46
net income per share	86.1	18.26	371.52
operating cash flow per share	125.31	207.78	-39.69
free cash flow per share	52.7	154.7	-65.94
cash per share	811.38	811.22	0.02
book value per share	3525.01	3406.05	3.49
tangible book value per share	3259.95	3138.55	3.87
shareholders equity per share	3514.34	3395.75	3.49
interest debt per share	112.96	213.76	-47.15
market cap	235679495025	209998772630	12.23
enterprise value	187794495025	172113772630	9.11
pe ratio	10.0	42.03	-76.20
price to sales ratio	3.1	2.88	7.43
pocfratio	27.49	14.78	86.06
pfcf ratio	65.38	19.84	229.43
pb ratio	0.98	0.9	8.43
ptb ratio	0.98	0.9	8.43
ev to sales	2.47	2.36	4.44
enterprise value over ebitda	17.62	20.4	-13.66
ev to operating cash flow	21.91	12.11	80.89
ev to free cash flow	52.09	16.26	220.28
earnings yield	0.02	0.01	320.19
free cash flow yield	0.02	0.05	-69.64
debt to equity	0.03	0.06	-49.25
debt to assets	0.02	0.04	-48.65
net debt to ebitda	-4.49	-4.49	-0.02
current ratio	2.56	2.48	3.30
interest coverage	61.29	37.05	65.44
income quality	1.46	11.38	-87.21
dividend yield	0.01	0.0	33191.31
payout ratio	0.51	0.01	7822.88
sales general and administrative to revenue	0	-0.44	100.00
research and ddevelopement to revenue	0	0.03	-100.00
intangibles to total assets	0.05	0.05	-3.13
capex to operating cash flow	0.58	0.26	126.83
capex to revenue	0.07	0.05	30.97
capex to depreciation	1.18	0.84	40.06
stock based compensation to revenue	0	0	NaN
graham number	2609.18	1181.14	120.90
roic	0.02	0.01	88.58
return on tangible assets	0.02	0.0	360.13
graham net net	544.81	483.08	12.78
working capital	117973000000	112059000000	5.28
tangible asset value	223020000000	214688000000	3.88
net current asset value	93537000000	87321000000	7.12
invested capital	252924000000	244482000000	3.45
average receivables	65827500000	65649000000	0.27
average payables	47086500000	44367500000	6.13
average inventory	61402500000	60720500000	1.12
days sales outstanding	79.38	79.85	-0.59
days payables outstanding	77.94	74.23	5.00
days of inventory on hand	101.72	96.71	5.18
receivables turnover	1.13	1.13	0.59
payables turnover	1.15	1.21	-4.76
inventory turnover	0.88	0.93	-4.93
roe	0.02	0.01	355.61
capex per share	72.62	53.08	36.80

• Negative

  ROE: Return on Equity (ROE) increased to 0.02 on 2024-06-30 Q1 from 0.01 on 2024-03-31 Q4, representing a change of 355.61%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 10.00 on 2024-06-30 Q1 from 42.03 on 2024-03-31 Q4, representing a change of -76.20%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.56 on 2024-06-30 Q1 from 2.48 on 2024-03-31 Q4, representing a change of 3.30%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.03 on 2024-06-30 Q1 from 0.06 on 2024-03-31 Q4, representing a change of -49.25%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 6713.01 which is higher than current price 2951, indicates the company may be undervalued.